1 Anti-infectious Disease Drugs Market Overview
1.1 Product Overview and Scope of Anti-infectious Disease Drugs
1.2 Anti-infectious Disease Drugs Segment by Type
1.2.1 Global Anti-infectious Disease Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Antibacterial Drugs
1.2.3 Antifungal Drugs
1.2.4 Antiviral Drugs
1.2.5 Antiparasitic Drugs
1.3 Anti-infectious Disease Drugs Segment by Application
1.3.1 Global Anti-infectious Disease Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Global Anti-infectious Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-infectious Disease Drugs Revenue 2018-2029
1.4.2 Global Anti-infectious Disease Drugs Sales 2018-2029
1.4.3 Global Anti-infectious Disease Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-infectious Disease Drugs Market Competition by Manufacturers
2.1 Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-infectious Disease Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-infectious Disease Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-infectious Disease Drugs, Product Type & Application
2.7 Anti-infectious Disease Drugs Market Competitive Situation and Trends
2.7.1 Anti-infectious Disease Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-infectious Disease Drugs Players Market Share by Revenue
2.7.3 Global Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-infectious Disease Drugs Retrospective Market Scenario by Region
3.1 Global Anti-infectious Disease Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-infectious Disease Drugs Global Anti-infectious Disease Drugs Sales by Region: 2018-2029
3.2.1 Global Anti-infectious Disease Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-infectious Disease Drugs Sales by Region: 2024-2029
3.3 Global Anti-infectious Disease Drugs Global Anti-infectious Disease Drugs Revenue by Region: 2018-2029
3.3.1 Global Anti-infectious Disease Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-infectious Disease Drugs Revenue by Region: 2024-2029
3.4 North America Anti-infectious Disease Drugs Market Facts & Figures by Country
3.4.1 North America Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.4.3 North America Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-infectious Disease Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.5.3 Europe Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-infectious Disease Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-infectious Disease Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.7.3 Latin America Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-infectious Disease Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-infectious Disease Drugs Sales by Type (2018-2029)
4.1.1 Global Anti-infectious Disease Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-infectious Disease Drugs Sales by Type (2024-2029)
4.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-infectious Disease Drugs Revenue by Type (2018-2029)
4.2.1 Global Anti-infectious Disease Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-infectious Disease Drugs Revenue by Type (2024-2029)
4.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-infectious Disease Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-infectious Disease Drugs Sales by Application (2018-2029)
5.1.1 Global Anti-infectious Disease Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-infectious Disease Drugs Sales by Application (2024-2029)
5.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-infectious Disease Drugs Revenue by Application (2018-2029)
5.2.1 Global Anti-infectious Disease Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-infectious Disease Drugs Revenue by Application (2024-2029)
5.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-infectious Disease Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aridis Pharmaceuticals
6.1.1 Aridis Pharmaceuticals Corporation Information
6.1.2 Aridis Pharmaceuticals Description and Business Overview
6.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.1.5 Aridis Pharmaceuticals Recent Developments/Updates
6.2 AiCuris
6.2.1 AiCuris Corporation Information
6.2.2 AiCuris Description and Business Overview
6.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AiCuris Anti-infectious Disease Drugs Product Portfolio
6.2.5 AiCuris Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sandoz Anti-infectious Disease Drugs Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Anhui Jingfang Medical Industry Co.,Ltd
6.4.1 Anhui Jingfang Medical Industry Co.,Ltd Corporation Information
6.4.2 Anhui Jingfang Medical Industry Co.,Ltd Description and Business Overview
6.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolio
6.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
6.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
6.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolio
6.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abbott Anti-infectious Disease Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Spero Therapeutics
6.6.1 Spero Therapeutics Corporation Information
6.6.2 Spero Therapeutics Description and Business Overview
6.6.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolio
6.7.5 Spero Therapeutics Recent Developments/Updates
6.8 Adlyfe, Inc.
6.8.1 Adlyfe, Inc. Corporation Information
6.8.2 Adlyfe, Inc. Description and Business Overview
6.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolio
6.8.5 Adlyfe, Inc. Recent Developments/Updates
6.9 Advanced Life Sciences Holdings, Inc.
6.9.1 Advanced Life Sciences Holdings, Inc. Corporation Information
6.9.2 Advanced Life Sciences Holdings, Inc. Description and Business Overview
6.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolio
6.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
6.10 Affinium Pharmaceuticals
6.10.1 Affinium Pharmaceuticals Corporation Information
6.10.2 Affinium Pharmaceuticals Description and Business Overview
6.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.10.5 Affinium Pharmaceuticals Recent Developments/Updates
6.11 APP Pharmaceuticals
6.11.1 APP Pharmaceuticals Corporation Information
6.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Description and Business Overview
6.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.11.5 APP Pharmaceuticals Recent Developments/Updates
6.12 Aquapharm Biodiscovery
6.12.1 Aquapharm Biodiscovery Corporation Information
6.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Description and Business Overview
6.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolio
6.12.5 Aquapharm Biodiscovery Recent Developments/Updates
6.13 Basilea Pharmaceutica AG
6.13.1 Basilea Pharmaceutica AG Corporation Information
6.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Description and Business Overview
6.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolio
6.13.5 Basilea Pharmaceutica AG Recent Developments/Updates
6.14 Biophage Pharma, Inc.
6.14.1 Biophage Pharma, Inc. Corporation Information
6.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Description and Business Overview
6.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolio
6.14.5 Biophage Pharma, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-infectious Disease Drugs Industry Chain Analysis
7.2 Anti-infectious Disease Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-infectious Disease Drugs Production Mode & Process
7.4 Anti-infectious Disease Drugs Sales and Marketing
7.4.1 Anti-infectious Disease Drugs Sales Channels
7.4.2 Anti-infectious Disease Drugs Distributors
7.5 Anti-infectious Disease Drugs Customers
8 Anti-infectious Disease Drugs Market Dynamics
8.1 Anti-infectious Disease Drugs Industry Trends
8.2 Anti-infectious Disease Drugs Market Drivers
8.3 Anti-infectious Disease Drugs Market Challenges
8.4 Anti-infectious Disease Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 抗感染症薬（こうかんせんしょうやく）とは、感染症の原因となる微生物に対抗するために使用される薬剤です。感染症はウイルス、細菌、真菌、寄生虫など、様々な微生物によって引き起こされる疾患であり、これらの微生物を排除、抑制、またはその作用を阻害することを目的としています。 抗感染症薬の定義としては、感染症の病原体に特異的に作用し、病気の進行を防いだり、治療を行ったりする薬剤を指します。これは、人間の体内で病原体が増殖するのを阻止することを目的としており、また患者自身の免疫系を助けることによって感染症から回復させる役割も果たします。 抗感染症薬の特徴には、幅広い種類の病原微生物に対する活動性があります。例えば、抗バイ菌薬は細菌に対して、抗ウイルス薬はウイルスに対して使用されます。また、それぞれの薬剤は特定のメカニズムで病原体を攻撃するため、効果的な治療のためには適切な薬剤を選択する必要があります。また、抗感染症薬は一般に治療の早期段階で使用されることが多く、重篤な症状を引き起こす前にその作用を発揮します。 抗感染症薬の種類は大きく分けて、抗細菌薬、抗ウイルス薬、抗真菌薬、抗寄生虫薬に分類されます。抗細菌薬は細菌に対するもので、ペニシリン系やセフェム系、マクロライド系などが含まれます。これらは細菌の細胞壁を破壊したり、タンパク質の合成を阻害したりすることでその増殖を抑えます。抗ウイルス薬については、インフルエンザウイルスやHIVなど特定のウイルスに対して効果的であり、ウイルスの複製を妨げる薬剤が開発されています。抗真菌薬は真菌感染症に使用され、アムホテリシンBやフルコナゾールなどが代表的です。抗寄生虫薬は、マラリアや肝蛭症など寄生虫による疾患に使用されます。 抗感染症薬はその特性上、特定の感染症に対する有効性が求められますが、一方で抗生物質耐性の問題も抱えています。これは細菌が持つ遺伝的変異により、抗生物質が効かなくなる現象です。耐性を持った細菌が増加することは、治療が困難になる要因の一つであるため、これを抑制するための研究や新薬の開発が進められています。 抗感染症薬の用途は非常に多岐にわたります。例えば、細菌感染による肺炎や尿路感染、皮膚感染症など、日常的な感染症の治療から、重篤な感染症に対する救命的な治療まで多様です。また、ウイルス感染に対しても、インフルエンザウイルスに対する治療やHIV感染症の治療のための薬剤が用いられています。 関連技術としては、抗感染症薬の研究開発が進む中で、さまざまなバイオテクノロジーや分子生物学の進歩が重要な役割を果たしています。例えば、薬剤の作用機序を解明し、新しい標的を見つけ出すためのゲノム解析や、高速なスクリーニング技術が利用されており、効率的な薬剤の開発が期待されています。また、免疫療法やワクチン開発も重要な関連技術であり、これにより感染症の予防や治療の新たな展望が開けています。 総じて、抗感染症薬は現代の医療において欠かせない存在であり、様々な微生物に対抗するための重要な武器です。その効果を最大限に引き出すためには、正しい使用法と新薬の開発、さらには耐性問題への対応が必要不可欠です。今後も、抗感染症薬の研究は進むことでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
